Cataract

A 70-year-old Caucasian man presented for an updated spectacle prescription. Ocular history included cataracts, monovision RK performed in 1997 and “damage to the back of my right eye.” Medically, the patient reported only a history of prostate cancer 11 years prior, for which he received treatment. Medications included a multivitamin. He denied any current or past use of tobacco, alcohol or recreational drugs.

In our cover story of this issue of Ocular Surgery News, we explore the ASCRS Cornea Clinical Committee’s protocol for treating dry eye. I was part of this committee during the early days of Chris Starr formulating the protocol. What he and the committee eventually produced was an incredibly cohesive approach to ocular surface disease using today’s most modern tools.

ATLANTA – Innovative therapeutic delivery, neurosensory treatment and lid therapies will change the management of ocular surface disease in the future, an expert panel said here at the OIS@SECO meeting.

KOLOA, Hawaii — At Hawaiian Eye 2020, Zaina Al-Mohtaseb, MD, associate professor of ophthalmology at Baylor College of Medicine, gives her presentation on the objective diagnosis of dysfunctional lens syndrome and cataract.

The final entry for this corneal transplant miniseries will explore transplant-specific risks, recovery and expected time to visual stability of the different transplants, as well as postoperative astigmatism and suture manipulation.

ORLANDO — Using surgical videos, Steven G. Safran, MD, gives a comprehensive overview of pearls he has learned in performing the Yamane double-needle intrascleral haptic fixation technique in his presentation from Cataract Surgery: Telling It Like It Is.

Patients who underwent cataract surgery showed increased anterior chamber depth postoperatively, which correlated with refractive error.

ATLANTA — “Moving MIGS earlier in our treatment algorithm has been great for patients and aligns with interventional glaucoma, where we’re taking a more proactive approach for these patients,” Mitch Ibach, OD, FAAO, said at SECO.

Cosmetic iris implants are non-FDA-approved procedures that can result in severe, potentially blinding complications.

MARRAKECH, Morocco — At the European Society of Cataract and Refractive Surgeons Winter Meeting, Richard Packard, MD, speaks about current trends in IOL technology. New options aim at extending depth of focus but not at the cost of decreasing quality of vision and causing dysphotopsia.